According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:18 PM, company Director, Scott Randal W. disclosed buying 312,500 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $5,000,000 in total. As […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:17 PM, company Director, Baker Bros. Advisors Lp disclosed buying 6,250,000 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $100,000,000 in total. […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:16 PM, company Sr. Vice President, R&D, Ramakrishnan Ramesh disclosed buying 1,000 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $16,000 in […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:13 PM, company Director, Posard Matthew L. disclosed buying 62,500 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $1,000,000 in total. As […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 06:01 PM, company Chief Financial Officer, Moody John Roger Jr disclosed buying 1,700 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $27,200 […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 05:59 PM, company Sr. Vice President, Operations, Liu Douglas disclosed buying 4,000 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was worth $64,000 in […]
According to Talis Biomedical Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 05:55 PM, company Chief of Staff, Sr. VP, Legal, Flick Karen E. disclosed buying 2,000 shares at a cost of $16.00. At the time of this transaction (Feb 17), this trade was […]
According to Kkr Credit Opportunities Portfolio’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 05:54 PM, company 10% Owner, Kkr Financial Holdings Llc disclosed buying 1,960,000 shares at a cost of $25.00. At the time of this transaction (Mar 03), this trade was worth $49,000,000 […]
According to Molecular Templates, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 05:28 PM, company 10% Owner, Biotech Target N V disclosed buying 1,185,770 shares at a cost of $12.65. At the time of this transaction (Feb 18), this trade was worth $14,999,991 in […]
According to Applied Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 19 05:17 PM, company 10% Owner, Alexandria Real Estate Equitie disclosed buying 43,478 shares at a cost of $23.00. At the time of this transaction (Feb 17), this trade was worth $999,994 in […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
